Turkey offers advanced ovarian cancer treatment through several hospitals accredited by the Joint Commission International. Leading facilities include Anadolu Medical Center, Valued Med Hub Hospitals, and Memorial Şişli Hospital. These institutions provide minimally invasive surgery, HIPEC (Hyperthermic Intraperitoneal Chemotherapy), and targeted therapy. The five-year survival rate for ovarian cancer patients in Turkey reaches 75%, with early-stage treatment success exceeding 80% thanks to precise diagnostics and individualized treatment approaches.
Anadolu Medical Center, affiliated with Johns Hopkins Medicine, implements a multidisciplinary approach following American treatment standards. Valued Med Hub Hospitals, holding the International Health Tourism Authorization Certificate, specializes in oncology services for international patients. Memorial Şişli Hospital, the first Turkish hospital with JCI accreditation, has achieved a 90% success rate in organ transplants, demonstrating its capability in complex medical procedures.